Follow
Lajos Raduly
Title
Cited by
Cited by
Year
A comprehensive review on MAPK: a promising therapeutic target in cancer
C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ...
Cancers 11 (10), 1618, 2019
4382019
Progresses towards safe and efficient gene therapy vectors
S Chira, CS Jackson, I Oprea, F Ozturk, MS Pepper, I Diaconu, C Braicu, ...
Oncotarget 6 (31), 30675, 2015
2252015
Overview upon miR-21 in lung cancer: focus on NSCLC
C Bica-Pop, R Cojocneanu-Petric, L Magdo, L Raduly, D Gulei, ...
Cellular and Molecular Life Sciences 75, 3539-3551, 2018
1672018
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
R Cojocneanu Petric, C Braicu, L Raduly, O Zanoaga, N Dragos, ...
OncoTargets and therapy, 2053-2066, 2015
822015
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
D Gulei, L Magdo, A Jurj, L Raduly, R Cojocneanu-Petric, A Moldovan, ...
Cell Death & Disease 9 (2), 66, 2018
662018
Implications of dietary ω‑3 and ω‑6 polyunsaturated fatty acids in breast cancer
O Zanoaga, A Jurj, L Raduly, R Cojocneanu‑Petric, E Fuentes‑Mattei, ...
Experimental and therapeutic medicine 15 (2), 1167-1176, 2018
642018
SERS-based differential diagnosis between multiple solid malignancies: Breast, colorectal, lung, ovarian and oral cancer
V Moisoiu, A Stefancu, D Gulei, R Boitor, L Magdo, L Raduly, S Pasca, ...
International journal of nanomedicine, 6165-6178, 2019
512019
Inhibitory effect of CAPE and kaempferol in colon cancer cell lines—possible implications in new therapeutic strategies
L Budisan, D Gulei, A Jurj, C Braicu, O Zanoaga, R Cojocneanu, L Pop, ...
International journal of molecular sciences 20 (5), 1199, 2019
432019
Aberrant miRNAs expressed in HER-2 negative breast cancers patient
C Braicu, L Raduly, G Morar-Bolba, R Cojocneanu, A Jurj, LA Pop, ...
Journal of Experimental & Clinical Cancer Research 37, 1-16, 2018
422018
miR‐181a/b therapy in lung cancer: reality or myth?
C Braicu, D Gulei, R Cojocneanu, L Raduly, A Jurj, E Knutsen, GA Calin, ...
Molecular oncology 13 (1), 9-25, 2019
362019
Plasma and tissue specific miRNA expression pattern and functional analysis associated to colorectal cancer patients
R Cojocneanu, C Braicu, L Raduly, A Jurj, O Zanoaga, L Magdo, A Irimie, ...
Cancers 12 (4), 843, 2020
342020
The extensive role of miR-155 in malignant and non-malignant diseases
D Gulei, L Raduly, E Broseghini, M Ferracin, I Berindan-Neagoe
Molecular aspects of medicine 70, 33-56, 2019
342019
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression
C Braicu, R Buiga, R Cojocneanu, M Buse, L Raduly, LA Pop, S Chira, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 1-17, 2019
332019
The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer “Omics”
CA Ciocan-Cartita, A Jurj, M Buse, D Gulei, C Braicu, L Raduly, ...
International Journal of Molecular Sciences 20 (10), 2576, 2019
262019
Spontaneous and induced animal models for cancer research
A Onaciu, R Munteanu, VC Munteanu, D Gulei, L Raduly, RI Feder, ...
Diagnostics 10 (9), 660, 2020
232020
Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms
C Braicu, D Gulei, L Raduly, A Harangus, A Rusu, I Berindan-Neagoe
Molecular aspects of medicine 70, 90-105, 2019
232019
Sensitizer drugs for the treatment of temozolomide-resistant glioblastoma
A Baritchii, A Jurj, O Soritau, C Tomuleasa, L Raduly, O Zanoaga, ...
J buon 21 (1), 199-207, 2016
192016
New insights in gene expression alteration as effect of paclitaxel drug resistance in triple negative breast cancer cells
A Jurj, LA Pop, O Zanoaga, CA Ciocan-Cārtiţă, R Cojocneanu, ...
Cell. Physiol. Biochem 54, 648-664, 2020
182020
Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells
TC Obasi, C Braicu, BC Iacob, E Bodoki, A Jurj, L Raduly, I Oniga, ...
Cancer Management and Research 10, 5709, 2018
182018
Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology
C Braicu, S Selicean, R Cojocneanu-Petric, R Lajos, O Balacescu, ...
BMC genomics 17, 1-9, 2016
182016
The system can't perform the operation now. Try again later.
Articles 1–20